Inadequate social support decreases survival in decompensated liver cirrhosis patients

Gastroenterol Hepatol. 2023 Jan;46(1):28-38. doi: 10.1016/j.gastrohep.2022.04.006. Epub 2022 May 13.
[Article in English, Spanish]

Abstract

Introduction: Inadequate social support is associated with higher mortality both in the general population and in patients with chronic diseases. There are no studies that have described social support in liver cirrhosis and its impact on prognosis.

Objectives: To analyze the impact social support has in the survival of patients with decompensated cirrhosis.

Methods: Prospective multicentric cohort study (2016-2019). Patients with decompensated liver cirrhosis were included. Epidemiological, clinical and social variables were collected, using the validated Medical Outcomes Study Social Support Survey, with a 12-month follow-up.

Results: A total of 127 patients were included, of which 79.5% were men. The most common etiology of cirrhosis was alcohol (74.8%), mean age was 60 years (SD 10.29), mean MELD was 15.6 (SD 6.3) and most of the patients had a Child-Pugh B (53.5%) or C (35.4%). In the assessment of social support, we observed that most of the patients (92.2%) had adequate global support. At the end of the follow-up (median 314 days), 70.1% of the patients survived. The 1-year survival rate in patients with inadequate global social support was 30%, compared to 73.5% in the presence of social support. In multivariate Cox regression analysis, inadequate social support predicted survival with an adjusted HR of 5.5 (95% CI 2,3-13,4) independently of MELD (HR 1.1, 95% CI 1-1.2), age (HR 1, 95% CI 1-1.1) and hepatocarcinoma (HR 10.6, 95% CI 4.1-27.4).

Conclusion: Adequate social support improves survival in liver cirrhosis, independently of clinical variables. Social intervention strategies should be considered for their management.

Keywords: Actividades preventivas; Análisis de supervivencia; Cirrosis hepática; Liver cirrhosis; Mortalidad; Mortality; Preventive health services; Survival analysis.

MeSH terms

  • Cohort Studies
  • Female
  • Humans
  • Liver Cirrhosis* / complications
  • Liver Neoplasms* / complications
  • Male
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Severity of Illness Index